BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17276682)

  • 1. Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives.
    Sivakumar PM; Seenivasan SP; Kumar V; Doble M
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1695-700. PubMed ID: 17276682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DFT-based QSAR models to predict the antimycobacterial activity of chalcones.
    Barua N; Sarmah P; Hussain I; Deka RC; Buragohain AK
    Chem Biol Drug Des; 2012 Apr; 79(4):553-9. PubMed ID: 22151277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation, mechanism of action and quantitative structure-activity relationship studies of chalcones as antibacterial agents.
    Sivakumar PM; Priya S; Doble M
    Chem Biol Drug Des; 2009 Apr; 73(4):403-15. PubMed ID: 19291103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity and QSAR of chalcones against biofilm-producing bacteria isolated from marine waters.
    Sivakumar PM; Prabhawathi V; Doble M
    SAR QSAR Environ Res; 2010 Apr; 21(3-4):247-63. PubMed ID: 20544550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones.
    Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Palát K; Kaustová J; Danse HM; Möllmann U
    Pharmazie; 2003 Feb; 58(2):83-94. PubMed ID: 12641321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal activity, mechanism and QSAR studies on chalcones.
    Sivakumar PM; Muthu Kumar T; Doble M
    Chem Biol Drug Des; 2009 Jul; 74(1):68-79. PubMed ID: 19519746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimycobacterial activity of 5-arylidene derivatives of hydantoin.
    Kieć-Kononowicz K; Szymańska E
    Farmaco; 2002 Nov; 57(11):909-16. PubMed ID: 12484539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, SAR and antibacterial studies on novel chalcone oxazolidinone hybrids.
    Selvakumar N; Kumar GS; Azhagan AM; Rajulu GG; Sharma S; Kumar MS; Das J; Iqbal J; Trehan S
    Eur J Med Chem; 2007 Apr; 42(4):538-43. PubMed ID: 17150281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimycobacterial activity of some pyrido-1,2-thiazine derivatives.
    Malinka W; Redzicka A; Swiatek P
    Acta Pol Pharm; 2002; 59(6):439-42. PubMed ID: 12669767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety.
    Tomar V; Bhattacharjee G; Kamaluddin ; Kumar A
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5321-4. PubMed ID: 17719779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives.
    Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
    Farmaco; 1992; 47(7-8):1055-66. PubMed ID: 1445613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, spectral characterization and antimicrobial studies of novel series of allylidene based multifaceted chalcones analogues.
    Irshad M; Ali Q; Abbasi MA; Iram F; Saadia M; Ishfaq MH
    Pak J Pharm Sci; 2020 May; 33(3):987-995. PubMed ID: 33191222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR of Chalcones Utilizing Theoretical Molecular Descriptors.
    Nandi S; Bagchi MC
    Curr Comput Aided Drug Des; 2015; 11(2):184-93. PubMed ID: 26135340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents.
    Mohan Krishna K; Inturi B; Pujar GV; Purohit MN; Vijaykumar GS
    Eur J Med Chem; 2014 Sep; 84():516-29. PubMed ID: 25055342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. smegmatis using theoretical molecular descriptors.
    Bagchi MC; Mills D; Basak SC
    J Mol Model; 2007 Jan; 13(1):111-20. PubMed ID: 16932890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
    Raparti V; Chitre T; Bothara K; Kumar V; Dangre S; Khachane C; Gore S; Deshmane B
    Eur J Med Chem; 2009 Oct; 44(10):3954-60. PubMed ID: 19464085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, antifungal activity, and structure-activity relationship studies of chalcones and hybrid dihydrochromane-chalcones.
    Mellado M; Espinoza L; Madrid A; Mella J; Chávez-Weisser E; Diaz K; Cuellar M
    Mol Divers; 2020 Aug; 24(3):603-615. PubMed ID: 31161394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bis-chalcones and flavones: synthesis and antimicrobial activity.
    Husain A; Rashid M; Mishra R; Kumar D
    Acta Pol Pharm; 2013; 70(3):443-9. PubMed ID: 23757935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid-catalyzed synthesis of oxathiolone fused chalcones. Comparison of their activity toward various microorganisms and human cancer cells line.
    Konieczny MT; Konieczny W; Sabisz M; Skladanowski A; Wakieć R; Augustynowicz-Kopeć E; Zwolska Z
    Eur J Med Chem; 2007 May; 42(5):729-33. PubMed ID: 17300856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimycobacterial N-pyridinylsalicylamides, isosters of salicylamides.
    Waisser K; Drazková K; Kunes J; Klimesová V; Kaustová J
    Farmaco; 2004 Aug; 59(8):615-25. PubMed ID: 15262531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.